ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 176503 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 176503; 2) Community: the network communities that were significantly associated with the response to NSC 176503; 3) Molecule: the relationships between components within communities and NSC 176503; 4) MDR: the compounds that were significantly associated with the NSC 176503.

NSC Compound Enrichment Correlation
NSC 694509 Null 0.0434721470609156 0.57352735
NSC 696073 Null 0.0434721470609156 0.28031543
NSC 709974 Null 0.0434721470609156 0.23862456
NSC 717468 Null 0.0434721470609156 0.25011021
NSC 718781 Erlotinib hydrochloride 0.0434721470609156 -0.05469362
NSC 725098 Null 0.0434721470609156 0.17404826
NSC 726217 Combretastatin A4-analogue 0.0434721470609156 0.23861169
NSC 730009 cis-2,5,6,12,13-Pentahydro-6-methyl-(8,9-methylenedioxy)-3-n itro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0434721470609156 0.2306606
NSC 730691 Null 0.0434721470609156 0.099743275
NSC 732936 5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0434721470609156 0.15523013
Total:176  Current:142    [First] [Prev] [Next] [Last]